These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15857564)

  • 1. Factors influencing predisposition to sepsis in children with cancers and acquired immunodeficiencies unrelated to human immunodeficiency virus infection.
    Allen UD
    Pediatr Crit Care Med; 2005 May; 6(3 Suppl):S80-6. PubMed ID: 15857564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community respiratory virus infections in immunocompromised patients: hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infection.
    Kim YJ; Boeckh M; Englund JA
    Semin Respir Crit Care Med; 2007 Apr; 28(2):222-42. PubMed ID: 17458776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sepsis predisposition in children with human immunodeficiency virus.
    Hatherill M
    Pediatr Crit Care Med; 2005 May; 6(3 Suppl):S92-8. PubMed ID: 15857567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplantation represents one of the true modern advances in medicine, presenting new and effective treatments for organ and bone marrow failure and neoplastic disorders. Preface.
    Marr KA; Subramanian AK
    Infect Dis Clin North Am; 2010 Jun; 24(2):xiii-v. PubMed ID: 20466268
    [No Abstract]   [Full Text] [Related]  

  • 5. Varicella vaccination of immunocompromised children.
    Levin MJ
    J Infect Dis; 2008 Mar; 197 Suppl 2():S200-6. PubMed ID: 18419398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sepsis in the immunocompromised child: the least studied with the most to gain.
    Priebe GP
    Pediatr Crit Care Med; 2005 May; 6(3 Suppl):S78-9. PubMed ID: 15864109
    [No Abstract]   [Full Text] [Related]  

  • 7. Pediatric cancer patients in clinical trials of sepsis: factors that predispose to sepsis and stratify outcome.
    Tamburro R
    Pediatr Crit Care Med; 2005 May; 6(3 Suppl):S87-91. PubMed ID: 15857565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with immunodeficiency.
    Hannaman MJ; Ertl MJ
    Med Clin North Am; 2013 Nov; 97(6):1139-59. PubMed ID: 24182724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulation during sepsis in organ transplanted children.
    Angele MK; Loehe F; Faist E
    Minerva Pediatr; 2005 Oct; 57(5):259-68. PubMed ID: 16205609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolving risk factors for infectious complications of cancer therapy.
    Chanock S
    Hematol Oncol Clin North Am; 1993 Aug; 7(4):771-93. PubMed ID: 8354656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-myeloablative stem-cell transplantation in the treatment of malignant and non-malignant disorders.
    Shimoni A; Nagler A
    Isr Med Assoc J; 2002 Apr; 4(4):272-9. PubMed ID: 12001702
    [No Abstract]   [Full Text] [Related]  

  • 12. Current world literature. Infections of the immunocompromised host.
    Curr Opin Infect Dis; 2003 Dec; 16(6):636-9. PubMed ID: 15043067
    [No Abstract]   [Full Text] [Related]  

  • 13. Guideline on dental management of pediatric patients receiving chemotherapy, hematopoietic cell transplantation, and/or radiation.
    ;
    Pediatr Dent; 2005-2006; 27(7 Suppl):170-5. PubMed ID: 16541917
    [No Abstract]   [Full Text] [Related]  

  • 14. Congenital immunodeficiencies and sepsis.
    Orange JS
    Pediatr Crit Care Med; 2005 May; 6(3 Suppl):S99-S107. PubMed ID: 15857568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infectious diarrhea in transplant recipients: current challenges and future directions.
    Subramanian AK; Sears CL
    Transpl Infect Dis; 2007 Dec; 9(4):263-4. PubMed ID: 17986004
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical use of hematopoietic growth factors.
    Löwenberg B; Dale DC; Sheridan WP
    Rev Invest Clin; 1994 Apr; Suppl():33-40. PubMed ID: 7886306
    [No Abstract]   [Full Text] [Related]  

  • 17. Intermittent oral trimethoprim/sulfamethoxazole on two non-consecutive days per week is effective as Pneumocystis jiroveci pneumonia prophylaxis in pediatric patients receiving chemotherapy or hematopoietic stem cell transplantation.
    Ohata Y; Ohta H; Hashii Y; Tokimasa S; Ozono K; Hara J
    Pediatr Blood Cancer; 2009 Jan; 52(1):142-4. PubMed ID: 18819150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Histopathological findings of pulmonary complications in 16 patients who received allogeneic hematopoietic stem cell transplants].
    Iida H; Ri M; Niimi K; Harada T; Sao H
    Rinsho Ketsueki; 2005 Dec; 46(12):1273-8. PubMed ID: 16447799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccinations in children treated with standard-dose cancer therapy or hematopoietic stem cell transplantation.
    Patel SR; Chisholm JC; Heath PT
    Pediatr Clin North Am; 2008 Feb; 55(1):169-86, xi. PubMed ID: 18242320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.